Overview

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
0
Participant gender:
All
Summary
Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Etoricoxib
Criteria
Inclusion Criteria:

- Low back pain for previous 3 months and majority of days in last month

- Regular use of acetaminophen or NSAID to treat low back pain in past month

- Judged to be in otherwise good health

Exclusion Criteria:

- Low back pain that is due to secondary causes

- Radicular/myelopathic pain

- Surgery for low back pain within the past 6 months

- Active lawsuit or claim pertaining to their low back pain

- Disease that may confound the results of the study or pose risk to the patients

- Corticosteroid use in past month

- Previous participation in an MK0663 study